Our News
Alnylam's Kevin Fitzgerald, PhD on The Long Run Podcast - The Past and Future of RNAi Therapeutics
January 12, 2025
Alnylam’s Chief Scientific Officer Kevin Fitzgerald, PhD, recently spoke with journalist Luke Timmerman on The Long Run podcast. The conversation covered the past, present and future of RNAi therapeutics as well as Kevin’s career journey. Find out what it took to turn a kid without a strong sense of direction into a biotech leader determined to harness a revolution in biology for human health. And learn how the Alnylam team managed to overcome challenge after challenge to deliver RNAi therapeutics to target cells and create a transformative class of medicines that’s poised to help many additional patients with rare and common diseases.
